Bowling Green WBKO on MSN1d
Graves and Gilbert Clinic expands Pulmonary Care services in Bowling Green
The partnership will enhance the clinic’s ability to provide specialized respiratory care and reinforce its commitment to ...
Medicine Buffalo5h
Study: Mindfulness helps people with COPD manage anxiety, breathlessness, insomnia
Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice mindfulness reported significantly less severe symptoms of anxiety, ...
Study demonstrates feasibility, effectiveness of mobile care for COPD
A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...
Healthline7d
In the News: What’s the Connection Between COPD and Rural Areas?
People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.
News Nation on MSN3d
Ascension St. Vincent’s Riverside to offer breakthrough treatments for COPD/emphysema
St. Vincent’s Riverside is now offering a breakthrough treatment for patients diagnosed with chronic pulmonary obstructive ...
Censored Science Can’t Save Lives
Censoring research on how to deliver treatments to those most in need isn’t just nonsensical; it puts lives at risk and ...
Can drugs like Ozempic help with COPD?
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Rolling Out3d
Diabetes drugs show promise in reducing COPD complications
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
News Medical on MSN10d
Diabetes medications may help lower COPD flare-up risk, study finds
The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...
Healio10d
SGLT2s, GLP-1s reduce risk for COPD exacerbations
Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD ...